Exosomes: a potential biomarker and therapeutic targets in diabetic cardiomyopathy
ExRNA · 2024
DOI: 10.55092/exrna20240015 ↗Kurz gefasst
Fachartikel in der Zeitschrift ExRNA, 2024. Verfasst von Azhar Anwar und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Diabetic cardiomyopathy (DCM) refers to a complication that arises in diabetic patients and leads to various cardiac dysfunctions. These dysfunctions include oxidative stress, myocardial apoptosis, mitochondrial dysfunction, inflammation, lipotoxicity, fibrosis, impaired Ca²⁺ handling, and increased fatty acid utilization. Despite significant research efforts, the molecular mechanism underlying DCM remains incompletely understood. Recent studies have highlighted the role of exosomes, which are endogenous nanovesicles, in carrying detrimental components capable of initiating and propagating disease-related signaling events. In this review, we summarize the potential underlying mechanisms of DCM and discuss the potential use of exosomes in understanding the cellular mechanisms involved and exploring therapeutic approaches for DCM. These insights and opportunities may pave the way for new advancements in the field.
Zitieren
APA
Anwar, A., Ma, J., & Yin, X. (2024). Exosomes: a potential biomarker and therapeutic targets in diabetic cardiomyopathy. ExRNA. https://doi.org/10.55092/exrna20240015
Vancouver
Anwar A, Ma J, Yin X. Exosomes: a potential biomarker and therapeutic targets in diabetic cardiomyopathy. ExRNA. 2024. doi:10.55092/exrna20240015
BibTeX
@article{Anwar2024,
author = {Anwar, Azhar and Ma, Jizheng and Yin, Xin},
title = {Exosomes: a potential biomarker and therapeutic targets in diabetic cardiomyopathy},
journal = {ExRNA},
year = {2024},
doi = {10.55092/exrna20240015}
}
EUVIMED